CAS 506410-53-3: Luteolin 7-O-[2-(β-D-apiofuranosyl)-β-D-glucopyranoside]

Graveobioside A can be used in hyperuricemia and gout-resistant drugs or health foods.

Graveobioside A is a natural compound, specifically a type of iridoid glycoside, which is derived from certain plant species within the Lamiaceae family, notably the genus Teucrium. This compound has been identified and isolated through meticulous phytochemical analysis of these plants. The mode of action of Graveobioside A involves modulation of various biochemical pathways, primarily exhibiting anti-inflammatory, antioxidant, and potential antimicrobial activities. These effects are attributable to its capacity to interfere with signaling cascades and oxidative stress mechanisms at the cellular level. In terms of applications, Graveobioside A is of significant interest within the pharmacological and biomedical research fields. It is currently under investigation for its therapeutic potential in treating inflammatory diseases, due to its ability to modulate immune responses. Additionally, its antioxidant properties make it a candidate for studies focusing on oxidative stress-related conditions. The exploration of its antimicrobial activity also provides avenues for developing alternative treatments against resistant microbial strains. As research progresses, the understanding of Graveobioside A’s multifaceted roles continues to expand, underscoring its potential utility in various therapeutic contexts.